“Grades” for FDA Approvals: When Academics Weigh in on Regulation
This article was originally published in RPM Report
Executive Summary
Physicians and patients need a better understanding of the quality of clinical trial design and data used to approve drugs, say researchers in a study published in JAMA. That led them to suggest a grading system to add another layer of information to FDA approvals, adding another academic suggestion for elaborating, explaining and embellishing FDA action.